User menu

Refinement of 1p36 alterations not involving PRDM16 in myeloid and lymphoid malignancies.

Bibliographic reference Duhoux, François ; Ameye, Geneviève ; Lambot, Virginie ; Herens, Christian ; Lambert, Frédéric ; et. al. Refinement of 1p36 alterations not involving PRDM16 in myeloid and lymphoid malignancies.. In: PloS one, Vol. 6, no.10, p. e26311 (2011)
Permanent URL http://hdl.handle.net/2078.1/136679
  1. Gajecka Marzena, Saitta Sulagna C., Gentles Andrew J., Campbell Lindsey, Ciprero Karen, Geiger Elizabeth, Catherwood Anne, Rosenfeld Jill A., Shaikh Tamim, Shaffer Lisa G., Recurrent interstitial 1p36 deletions: Evidence for germline mosaicism and complex rearrangement breakpoints, 10.1002/ajmg.a.33733
  2. Battaglia Agatino, Del 1p36 syndrome: a newly emerging clinical entity, 10.1016/j.braindev.2004.03.011
  3. D’Angelo Carla S., Gajecka Marzena, Kim Chong A., Gentles Andrew J., Glotzbach Caron D., Shaffer Lisa G., Koiffmann Célia P., Further delineation of nonhomologous-based recombination and evidence for subtelomeric segmental duplications in 1p36 rearrangements, 10.1007/s00439-009-0650-9
  4. Carén H, Fransson S, Ejeskär K, Kogner P, Martinsson T, Genetic and epigenetic changes in the common 1p36 deletion in neuroblastoma tumours, 10.1038/sj.bjc.6604032
  5. Cole K. A., Attiyeh E. F., Mosse Y. P., Laquaglia M. J., Diskin S. J., Brodeur G. M., Maris J. M., A Functional Screen Identifies miR-34a as a Candidate Neuroblastoma Tumor Suppressor Gene, 10.1158/1541-7786.mcr-07-2102
  6. Tivnan Amanda, Tracey Lorraine, Buckley Patrick G, Alcock Leah C, Davidoff Andrew M, Stallings Raymond L, MicroRNA-34a is a potent tumor suppressor molecule in vivo in neuroblastoma, 10.1186/1471-2407-11-33
  7. F Mitelman, 417 (1997)
  8. Lahortiga Idoya, V�zquez Iria, Belloni Elena, Rom�n Jos� P., Gasparini Patrizia, Novo Francisco J., Zudaire Isabel, Pelicci Pier G., Hern�ndez Jes�s M., Calasanz Mar�a J., Odero Mar�a D., FISH analysis of hematological neoplasias with 1p36 rearrangements allows the definition of a cluster of 2.5�Mb included in the minimal region deleted in 1p36 deletion syndrome, 10.1007/s00439-005-1268-1
  9. BJ Dave, Clin Cancer Res, 5, 1401 (1999)
  10. Höglund Mattias, Sehn Laurie, Connors Joseph M., Gascoyne Randy D., Siebert Reiner, Säll Torbjörn, Mitelman Felix, Horsman Douglas E., Identification of cytogenetic subgroups and karyotypic pathways of clonal evolution in follicular lymphomas : Cytogenetic Subgroups of Follicular Lymphoma, 10.1002/gcc.10314
  11. White P. S., Maris J. M., Beltinger C., Sulman E., Marshall H. N., Fujimori M., Kaufman B. A., Biegel J. A., Allen C., Hilliard C., A region of consistent deletion in neuroblastoma maps within human chromosome 1p36.2-36.3., 10.1073/pnas.92.12.5520
  12. Dave Bhavana J., Pickering Diane L., Hess Michelle M., Weisenburger Dennis D., Armitage James O., Sanger Warren G., Deletion of Cell Division Cycle 2-Like 1 Gene Locus on 1p36 in Non-Hodgkin Lymphoma, 10.1016/s0165-4608(98)00138-1
  13. White Peter S., Kaufman Bruce A., Marshall Helen N., Brodeur Garrett M., Use of the single-strand conformation polymorphism technique to detect loss of heterozygosity in neuroblastoma, 10.1002/gcc.2870070207
  14. W Ellmeier, EMBO J, 11, 2563 (1992)
  15. H Enomoto, Oncogene, 9, 2785 (1994)
  16. RJ Davis, Cancer Res, 54, 2869 (1994)
  17. Oswald Claudia, Stiewe Thorsten, In good times and bad: p73 in cancer, 10.4161/cc.7.12.6148
  18. Cohen Jr. M. Michael, Perspectives onRUNXgenes: An update, 10.1002/ajmg.a.33021
  19. Ferrand N., Atfi A., Prunier C., The Oncoprotein c-Ski Functions as a Direct Antagonist of the Transforming Growth Factor-  Type I Receptor, 10.1158/0008-5472.can-09-4088
  20. N Mochizuki, Blood, 96, 3209 (2000)
  21. Odero María D., Vizmanos José L., Román José P., Lahortiga Idoya, Panizo Carlos, Calasanz María J., Zeleznik-Le Nancy J., Rowley Janet D., Novo Francisco J., A novel gene,MDS2,is fused toETV6/TELin a t(1;12)(p36.1;p13) in a patient with myelodysplastic syndrome : MDS2on 1p36.1 Is a NovelETV6Partner in MDS, 10.1002/gcc.10090
  22. Cheung K-John J., Delaney Allen, Ben-Neriah Susana, Schein Jacquie, Lee Tang, Shah Sohrab P., Cheung Dorothy, Johnson Nathalie A., Mungall Andrew J., Telenius Adele, Lai Betty, Boyle Merrill, Connors Joseph M., Gascoyne Randy D., Marra Marco A., Horsman Douglas E., High resolution analysis of follicular lymphoma genomes reveals somatic recurrent sites of copy-neutral loss of heterozygosity and copy number alterations that target single genes, 10.1002/gcc.20780
  23. LG Shaffer (2009)
  24. FP Duhoux (2010)
  25. Tilman G, Loriot A, Van Beneden A, Arnoult N, Londoño-Vallejo J A, De Smet C, Decottignies A, Subtelomeric DNA hypomethylation is not required for telomeric sister chromatid exchanges in ALT cells, 10.1038/onc.2009.23
  26. Kang Min Ah, Kim Jong-Tae, Kim Joo Heon, Kim Soo-Young, Kim Young Ho, Yeom Young Il, Lee Younghee, Lee Hee Gu, Upregulation of the cycline kinase subunit CKS2 increases cell proliferation rate in gastric cancer, 10.1007/s00432-008-0510-3
  27. Odero M D, Grand F H, Iqbal S, Ross F, Roman J P, Vizmanos J L, Andrieux J, Laï J L, Calasanz M J, Cross N C P, Disruption and aberrant expression of HMGA2 as a consequence of diverse chromosomal translocations in myeloid malignancies, 10.1038/sj.leu.2403605
  28. Sakai Ikuya, Tamura Tatsushiro, Narumi Hirosi, Uchida Naoyuki, Yakushijin Yoshihiro, Hato Takaaki, Fujita Shigeru, Yasukawa Masaki, NovelRUNX1-PRDM16 fusion transcripts in a patient with acute myeloid leukemia showing t(1;21)(p36;q22), 10.1002/gcc.20241
  29. Nguyen TuDung T., Ma Lisa N., Slovak Marilyn L., Bangs Charles D., Cherry Athena M., Arber Daniel A., Identification of novelRunx1 (AML1) translocation partner genesSH3D19,YTHDf2, andZNF687 in acute myeloid leukemia, 10.1002/gcc.20355
  30. Rajgopal Achuthan, Carr Ian M., Leek Jack P., Hodge Donald, Bell Sandra M., Roberts Paul, Horgan Kieran, Bonthron David T., Selby Peter J., Markham Alexander F., MacLennan Kenneth A., Detection by fluorescence in situ hybridization of microdeletions at 1p36 in lymphomas, unidentified on cytogenetic analysis, 10.1016/s0165-4608(02)00740-9
  31. Ross C. W., Ouillette P. D., Saddler C. M., Shedden K. A., Malek S. N., Comprehensive Analysis of Copy Number and Allele Status Identifies Multiple Chromosome Defects Underlying Follicular Lymphoma Pathogenesis, 10.1158/1078-0432.ccr-07-0456
  32. Schwaenen Carsten, Viardot Andreas, Berger Hilmar, Barth Thomas F. E., Bentink Stefan, Döhner Hartmut, Enz Martina, Feller Alfred C., Hansmann Martin-Leo, Hummel Michael, Kestler Hans A., Klapper Wolfram, Kreuz Markus, Lenze Dido, Loeffler Markus, Möller Peter, Müller-Hermelink Hans-Konrad, Ott German, Rosolowski Maciej, Rosenwald Andreas, Ruf Sandra, Siebert Reiner, Spang Rainer, Stein Harald, Truemper Lorenz, Lichter Peter, Bentz Martin, Wessendorf Swen, , Microarray-based genomic profiling reveals novel genomic aberrations in follicular lymphoma which associate with patient survival and gene expression status, 10.1002/gcc.20617
  33. Cheung K.-J. J., Shah S. P., Steidl C., Johnson N., Relander T., Telenius A., Lai B., Murphy K. P., Lam W., Al-Tourah A. J., Connors J. M., Ng R. T., Gascoyne R. D., Horsman D. E., Genome-wide profiling of follicular lymphoma by array comparative genomic hybridization reveals prognostically significant DNA copy number imbalances, 10.1182/blood-2008-02-140616
  34. Hofmann Wolf-K, Takeuchi Seisho, Xie Dong, Miller Carl W, Hoelzer Dieter, Koeffler H.Phillip, Frequent loss of heterozygosity in the region of D1S450 at 1p36.2 in myelodysplastic syndromes, 10.1016/s0145-2126(01)00037-6
  35. Mori Naoki, Morosetti Roberta, Mizoguchi Hideaki, Koeffler H. Phillip, Progression of myelodysplastic syndrome: allelic loss on chromosomal arm 1p, 10.1046/j.1365-2141.2003.04434.x
  36. Henrich K.-O., Bauer T., Schulte J., Ehemann V., Deubzer H., Gogolin S., Muth D., Fischer M., Benner A., Konig R., Schwab M., Westermann F., CAMTA1, a 1p36 Tumor Suppressor Candidate, Inhibits Growth and Activates Differentiation Programs in Neuroblastoma Cells, 10.1158/0008-5472.can-10-3014
  37. Martinez-Delgado Beatriz, Melendez Barbara, Cuadros Marta, Jose Garcia Maria, Nomdedeu Josep, Rivas Carmen, Fernandez-Piqueras Jose, Benítez Javier, Frequent inactivation of thep73gene by abnormal methylation or LOH in non-Hodgkin's lymphomas : p73Methylation and LOH in NHL, 10.1002/ijc.10618
  38. Stoffel Archontoula, Filippa Daniel, Rao Pulivarthi H., The p73 locus is commonly deleted in non-Hodgkin’s lymphomas, 10.1016/j.leukres.2004.04.010
  39. M Urashima, Leukemia, 10, 1576 (1996)
  40. Mayr C., Chromosomal translocations are associated with poor prognosis in chronic lymphocytic leukemia, 10.1182/blood-2005-05-2093
  41. Peruta Marco, Giagulli Cinzia, Laudanna Carlo, Scarpa Aldo, Sorio Claudio, RHOA and PRKCZ control different aspects of cell motility in pancreatic cancer metastatic clones, 10.1186/1476-4598-9-61
  42. T Waerner, Cell Growth Differ, 12, 201 (2001)
  43. Okawa E R, Gotoh T, Manne J, Igarashi J, Fujita T, Silverman K A, Xhao H, Mosse Y P, White P S, Brodeur G M, Expression and sequence analysis of candidates for the 1p36.31 tumor suppressor gene deleted in neuroblastomas, 10.1038/sj.onc.1210675
  44. Cheung K.-J. J., Johnson N. A., Affleck J. G., Severson T., Steidl C., Ben-Neriah S., Schein J., Morin R. D., Moore R., Shah S. P., Qian H., Paul J. E., Telenius A., Relander T., Lam W., Savage K., Connors J. M., Brown C., Marra M. A., Gascoyne R. D., Horsman D. E., Acquired TNFRSF14 Mutations in Follicular Lymphoma Are Associated with Worse Prognosis, 10.1158/0008-5472.can-10-2460
  45. AA Alizadeh (2011)
  46. I Theate, Ann Oncol, 22, iv211 (2011)
  47. Katzenberger T., Kalla J., Leich E., Stocklein H., Hartmann E., Barnickel S., Wessendorf S., Ott M. M., Muller-Hermelink H. K., Rosenwald A., Ott G., A distinctive subtype of t(14;18)-negative nodal follicular non-Hodgkin lymphoma characterized by a predominantly diffuse growth pattern and deletions in the chromosomal region 1p36, 10.1182/blood-2008-07-168682
  48. O'Shea D., O'Riain C., Gupta M., Waters R., Yang Y., Wrench D., Gribben J., Rosenwald A., Ott G., Rimsza L. M., Holte H., Cazier J.-B., Johnson N. A., Campo E., Chan W. C., Gascoyne R. D., Young B. D., Staudt L. M., Lister T. A., Fitzgibbon J., Regions of acquired uniparental disomy at diagnosis of follicular lymphoma are associated with both overall survival and risk of transformation, 10.1182/blood-2008-08-174953
  49. Cigudosa Juan C., Parsa Nasser Z., Louie Diane C., Filippa Daniel A., Jhanwar Suresh C., Johansson Bertil, Mitelman Felix, Chaganti R.S.K., Cytogenetic analysis of 363 consecutively ascertained diffuse large B-cell lymphomas, 10.1002/(sici)1098-2264(199906)25:2<123::aid-gcc8>3.0.co;2-4
  50. Lestou Valia S., Ludkovski Olga, Connors Joseph M., Gascoyne Randy D., Lam Wan L., Horsman Douglas E., Characterization of the recurrent translocation t(1;1)(p36.3;q21.1-2) in non-Hodgkin lymphoma by multicolor banding and fluorescence in situ hybridization analysis, 10.1002/gcc.10181
  51. Zenz T., Mohr J., Eldering E., Kater A. P., Buhler A., Kienle D., Winkler D., Durig J., van Oers M. H. J., Mertens D., Dohner H., Stilgenbauer S., miR-34a as part of the resistance network in chronic lymphocytic leukemia, 10.1182/blood-2008-08-172254
  52. Jain Devanshi, Cooper Julia Promisel, Telomeric Strategies: Means to an End, 10.1146/annurev-genet-102108-134841
  53. Sowa Mathew E., Bennett Eric J., Gygi Steven P., Harper J. Wade, Defining the Human Deubiquitinating Enzyme Interaction Landscape, 10.1016/j.cell.2009.04.042